September 2026
09 September 2026 17:30
Building a successful biotech company requires more than great science, it demands founders who demonstrate readiness, resilience and the ability to manage risk effectively. This London BioWednesday event will explore how life science entrepreneurs can…
10 September 2026 08:30
Join the One Nucleus community for a relaxed coffee morning, generously supported by Howard Group and hosted at Suite 7 at The Works, Unity Campus.
Start your day with great coffee and informal networking alongside fellow professionals from across the life…
16 September 2026 08:30
For R&D businesses, finding and managing the right workspace is a critical business decision and one that can bring significant operational responsibilities, lease commitments and unexpected challenges.
This practical roundtable will explore the…
17 September 2026 10:00
Multi-pass membrane proteins, including GPCRs, ion channels, and transporters, play essential roles in cellular signalling, communication, and homeostasis. As the targets of many modern therapeutics, they remain among the most important yet challenging…
21 September 2026 16:00
For the next in the series looking at the future of biopharma R&D in the UK and its associated employment opportunities, this interactive webinar provides the opportunity to hear from the NIHR Industry Hub about the environment for commercial clinical…
24 September 2026 10:00
The financial and people cost of attending events and conferences when adding in travel, accommodation, preparation and the follow up can be one of the more significant spend for a life science company. The expense of investor and partnering conferences,…
24 September 2026 16:30
Kick off your Genesis 2026 journey with us on 24 September for an evening of ideas, connections and celebration.
Bringing together professionals from across the life sciences ecosystem, the Genesis Launch Event will explore the plans and opportunities for…
30 September 2026 08:30
Findings from Bidwells’ report Capital, clusters and the scale-up gap show that overseas investors are not peripheral to UK life sciences scale-up funding. Since 2022, 81% of UK life sciences growth capital has come from rounds involving at least one…
30 September 2026 12:00
This session will be led by Eleanor Freeman of Cambridge Employment Law LLP.
Session details to follow soon.
Programme:
12.00 - Arrival and Lunch
12.30 - Presentation: Eleanor Freeman, Cambridge Employment Law LLP
14.00 - Close
This…
October 2026
07 October 2026 13:30
AI is being ubiquitously touted as the answer to many challenges in business and R&D, yet the value of human input and judgement based on experience and clear understanding of an individual need cannot be easily replaced. It remains the case that people…